AIDS Treatment News logo      

August 21, 2009

FDA Details Access to 'Investigational' Drugs

"Anything FDA does to promote transparency is good for us," said Lynda Dee, a patient representative for the FDA's Antiviral Drugs Advisory Committee and a founding member of the AIDS Treatment Activist Coalition in Baltimore. "This will go far in helping people who need these new treatments."

Read more in Health Day - U.S. News and World Report, August 12, 2009.


Robert Reinhard said...

The FDA also publshed its rule on charging for drugs in a clinical trial and that has received scant attntion